The licence holder and the persons described and named in Annexure 1 shall at all times ensure that all medical devices distributed, irrespective of its registration status, comply with all the provisions of the Medicines and Related Substances Act, 1965, as amended and in particular with sections 14, 18, 18A, 18B, 18C, 19, 20, 22A, 22C, 22H, 23, 26, 28, 33 and the Regulations relating to Medical Devices 2, 3, 4, 5, 6, 13, 14, 17, 18, 19, 20, 21, 22, 23, 24, 25, 27, 28 and all relevant South African Health Products Regulatory Authority Guidelines
Download Here
Cost-effectiveness of Debrichem in managing hard-to-heal venous leg ulcers in the UK
Objective: To estimate whether the topical debriding agent, Debrichem, could potentially afford the UK’s National Health Service (NHS) a cost-effective intervention for the management of
